All Resources

Access to Medicine • July 06, 2022

Developing a Pan-Canadian Genomics Strategy: Innovative Medicines Canada Response

Learn more|View

Access to Medicine • February 12, 2022

Optimizing Patient Access to Precision Therapies: Preparing for the Emerging Era of Advanced Testing

Learn more|View

Access to Medicine • February 05, 2022

Bluesky Project

Reimagining Canada’s Approval and Reimbursement System for Innovative Medicines February 2022…

Learn more|View

Ethics • January 01, 2022

2022 Code of Ethical Practices

Learn more|View

November 25, 2021

Innovative Agreements Framework Industry Oct 2021

Learn more|View

Economic Impact • November 19, 2021

Statistics Canada: The Canadian Research and Development Pharmaceutical Sector 2018

Statistic’s Canada outlines the economic impact of the Canadian research and development pharmaceutical sector….

Learn more|View

Access to Medicine • November 15, 2021

Research Note: Oncology Clinical Trials: Canada Within the International Context

Learn more|View

Drugs for Rare Diseases (DRD) • September 15, 2021

Addendum to IMC Submission on Drugs for Rare Diseases

Learn more|View

Private Drug Coverage • August 01, 2021

Cost Drivers: Analysis of Private Drug Plans in Canada 2021

Learn more|View

Patented Medicine Prices Review Board (PMPRB) • June 21, 2021

Proposed Guidelines Monitoring and Evaluation Plan

Learn more|View

Economic Impact • May 30, 2021

The Canadian Research and Development Pharmaceutical Sector

StatsCan examines the economic footprint made by Canada’s research and development pharmaceutical sector in 2018, including the contributions of Innovative Medicines Canada….

Learn more|View

Access to Medicine • May 18, 2021

Clinical Trials in Canada – Numbers

Learn more|View